0000-0001-5951-8910 About
A highly optimistic and proactive computational medicinal chemist with a Doctorate (PhD) degree in Pharmaceutical Chemistry. I am a passionate researcher and have a successful track record of executing lead identification and optimizing projects by applying molecular modeling techniques. I have sound knowledge of medicinal chemistry principles and their application in addressing drug design challenges. Synthesis and purification of small molecules. Experience in executing time-sensitive projects. Experience in working in close association with synthetic/Medicinal/organic chemists to execute the projects
I have actively contributed to 21 research publications and currently, I am engaged as Associate Professor at Sri Venkateshwara College of Pharmacy. In this role, I am also leading projects of B-Pharmacy and M-Pharmacy.
I actively participate in conferences, workshops, and symposiums to stay abreast of the latest developments in molecular modeling and drug discovery.
I welcome collaborations and conversations with fellow researchers, students, and professionals passionate about the intersection of molecular sciences and drug discovery. Let's embark on a journey of scientific exploration and innovation together!
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (17)
- NOVEL MEFENAMIC ACID-ANTIBIOTIC COMBINATIONS AS POTENTIAL INHIBITORS OF SARS-COV-2 MAIN PROTEASE Save
- In‐Silico Studies, Synthesis and Biological Assessment of Pyrrole Substituted Triazolo—Quinazoline Carbothioamide Derivatives as p38 MAP Kinase Inhibitors Save
- NOVEL SIMULTANEOUSSTABILITY-INDICATING ESTIMATION METHOD FOR DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE BYRP-HPLC: APPLICATIONTOAPIANDPHARMACEUTICAL DOSAGE FORMS Save
- Ensuring Confidentiality in Telemedicine Save
- Design, Synthesis, in vitro Anti‐inflammatory Activity and in silico Studies of Imidazole‐Based 1,2,3‐Triazole Hybrids Targeting p38 MAP Kinase Save
- Design, Synthesis, In‐silico Studies and Antiproliferative Evaluation of Novel Indazole Derivatives as Small Molecule Inhibitors of B‐Raf Save
- Synthesis, in-silico based virtual screening,anti-cancer potential of novel1,2,3-triazole-thiadiazole hybrid derivatives as Aurora kinase A (ARK-A) and Extracellular regulated kinase 2 (ERK2) dual inhibitors. Save
- Synthesis, in-silico based virtual screening,anti-cancer potential of novel1,2,3-triazole-thiadiazole hybrid derivatives as Aurora kinase A (ARK-A) and Extracellular regulated kinase 2 (ERK2) dual inhibitors Save
- Discovery of Novel 1,2,4‐Oxadiazolyl Triazole Hybrids as B‐Raf Inhibitors for the Treatment of Melanoma Save
- Discovery of N‐pyridoyl‐Δ2‐pyrazolines as Hsp90 inhibitors Save